Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
Dave Singh
Tuberc Respir Dis. 2020;83(3):185-194.   Published online 2020 Apr 29     DOI: https://doi.org/10.4046/trd.2020.0026
Citations to this article as recorded by Crossref logo
Review of Peripheral Blood Eosinophilia: Workup and Differential Diagnosis
Michael Dennis Weaver, Bianca Glass, Chance Aplanalp, Gauri Patel, Jeshrine Mazhil, Isabella Wang, Samir Dalia
Hemato.2024; 5(1): 81.     CrossRef
Investigating the rationale for COPD maintenance therapy prescription across Europe, findings from a multi-country study
Janwillem Kocks, António Jorge Ferreira, Per Bakke, Onno C. P. van Schayck, Heikki Ekroos, Nikolaos Tzanakis, Stéphane Soulard, Monika Haaksma-Herczegh, Montserrat Mestres-Simon, Malena Águila-Fuentes, Didier Cataldo
npj Primary Care Respiratory Medicine.2023;[Epub]     CrossRef
Eosinophil values in exacerbation and stable chronic obstructive pulmonary disease and its relationship to maintenance therapy in stable chronic obstructive pulmonary disease patients
Muhammad Fachri, Mochammad Hatta, Fira Indah Lestari, Risky Akaputra, Fatimah Fatimah, Athariq Wahab, Yunita Arliniy, Ressy Dwiyanti, Ahmad Syukri, Ade Rifka Junita, Andini Febrianti, Muhammad Reza Primaguna, Azhar Azhar
Annals of Medicine & Surgery.2023; 85(10): 4799.     CrossRef
Stepwise management of COPD: What is next after bronchodilation?
Marc Miravitlles, Kazuto Matsunaga, Michael Dreher
Therapeutic Advances in Respiratory Disease.2023;[Epub]     CrossRef
Chronic obstructive pulmonary disease and respiratory failure
Giulia Mussatti, Liliana Mazza, Simone Dini, Vincenzo Gianturco, Francesca Flavia Rossi, Mattia Brunori, Annalisa Paglia
Geriatric Care.2023;[Epub]     CrossRef
Interpreting blood eosinophil counts in health and obstructive lung disease
Yunus Çolak, Peter Lange
European Respiratory Journal.2022; 59(1): 2102180.     CrossRef
Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study
Iseul Yu, Sunmin Park, Se Hwa Hong, Min-Seok Chang, Seok Jeong Lee, Suk Joong Yong, Won-Yeon Lee, Sang-Ha Kim, Ji-Ho Lee
Journal of Personalized Medicine.2022; 12(7): 1189.     CrossRef
Defining Asthma–Chronic Obstructive Pulmonary Disease Overlap
Krystelle Godbout, Peter G. Gibson
Immunology and Allergy Clinics of North America.2022; 42(3): 507.     CrossRef
Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
Pradeesh Sivapalan, András Bikov, Jens-Ulrik Jensen
Diagnostics.2021; 11(2): 236.     CrossRef
Pharmacological treatment of stable chronic obstructive pulmonary disease
Dave Singh
Respirology.2021; 26(7): 643.     CrossRef
Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update
Anthony D. D’Urzo, Dave Singh, James F. Donohue, Kenneth R. Chapman, Robert A. Wise
Expert Review of Respiratory Medicine.2021; 15(9): 1093.     CrossRef
Word Embedding Reveals Cyfra 21-1 as a Biomarker for Chronic Obstructive Pulmonary Disease
Jeongwon Heo, Da Hye Moon, Yoonki Hong, So Hyeon Bak, Jeeyoung Kim, Joo Hyun Park, Byoung-Doo Oh, Yu-Seop Kim, Woo Jin Kim
Journal of Korean Medical Science.2021;[Epub]     CrossRef
Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
Jae-Hwa Choi, Keun-Bae Jeong, You Hyun Park, Iseul Yu, Seok Jeong Lee, Myoung Kyu Lee, Sang-Ha Kim, Won-Yeon Lee, Suk Joong Yong, Ji-Ho Lee
International Journal of Chronic Obstructive Pulmonary Disease.2021; Volume 16: 3229.     CrossRef
Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study
Jens Ellingsen, Christer Janson, Kristina Bröms, Karin Lisspers, Björn Ställberg, Marieann Högman, Andrei Malinovschi
ERJ Open Research.2021; 7(4): 00471-2021.     CrossRef